Akari Therapeutics Plc (AKTX)
8.72
-0.12
(-1.36%)
USD |
NASDAQ |
Oct 02, 16:00
8.65
-0.07
(-0.80%)
After-Hours: 20:00
Akari Therapeutics Max Drawdown (5Y) : 99.83% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.83% |
| August 31, 2026 | 99.83% |
| July 31, 2026 | 99.83% |
| June 30, 2026 | 99.83% |
| May 31, 2026 | 99.83% |
| April 30, 2026 | 99.83% |
| March 31, 2026 | 99.79% |
| February 28, 2026 | 99.71% |
| January 31, 2026 | 99.70% |
| December 31, 2025 | 99.68% |
| November 30, 2025 | 99.43% |
| October 31, 2025 | 99.16% |
| September 30, 2025 | 99.16% |
| August 31, 2025 | 99.02% |
| July 31, 2025 | 98.88% |
| June 30, 2025 | 98.88% |
| May 31, 2025 | 98.88% |
| April 30, 2025 | 98.88% |
| March 31, 2025 | 98.88% |
| February 28, 2025 | 98.88% |
| January 31, 2025 | 98.78% |
| December 31, 2024 | 98.78% |
| November 30, 2024 | 98.67% |
| October 31, 2024 | 98.63% |
| September 30, 2024 | 98.63% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.63% |
| July 31, 2024 | 98.63% |
| June 30, 2024 | 98.63% |
| May 31, 2024 | 98.63% |
| April 30, 2024 | 98.63% |
| March 31, 2024 | 98.19% |
| February 29, 2024 | 98.12% |
| January 31, 2024 | 97.88% |
| December 31, 2023 | 98.57% |
| November 30, 2023 | 98.57% |
| October 31, 2023 | 98.57% |
| September 30, 2023 | 98.57% |
| August 31, 2023 | 98.57% |
| July 31, 2023 | 98.57% |
| June 30, 2023 | 99.00% |
| May 31, 2023 | 99.23% |
| April 30, 2023 | 99.25% |
| March 31, 2023 | 99.28% |
| February 28, 2023 | 99.29% |
| January 31, 2023 | 99.29% |
| December 31, 2022 | 99.29% |
| November 30, 2022 | 99.29% |
| October 31, 2022 | 99.29% |
| September 30, 2022 | 99.29% |
| August 31, 2022 | 99.29% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| DBV Technologies SA | 98.19% |
| Cellectis SA | 97.08% |
| Bicycle Therapeutics Plc | 94.11% |
| Autolus Therapeutics Plc | 96.58% |
| Evaxion AS | 99.79% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -80.92 |
| Beta (5Y) | 1.434 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 128.4% |
| Historical Sharpe Ratio (5Y) | -0.5186 |
| Historical Sortino (5Y) | -1.300 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 47.01% |